Intra-Articular Injection of an Extracellular Vesicle Isolate to Treat Shoulder Osteoarthritis in an Athlete

Abstract

Cadaver and radiographic studies have demonstrated shoulder osteoarthritis (OA) in up to 33% of patients over the age of 60. Patients that present with shoulder OA have pain, crepitus and loss of glenohumeral motion. Limiting the ability to place your hand where you desire severely impairs activities of daily living. The nonsurgical treatments for shoulder OA, include shoulder exercises, the use of analgesics and non-steroidal anti-inflammatory medications. If these non-surgical treatments fail to relieve the OA impairment, the surgical treatment is total shoulder arthroplasty (TSA).